1.
Characteristics | All patients (n = 139) |
Age (year)* | 46.3 ± 11.5 |
Gender | |
Male | 113 (87.6%) |
Female | 16 (12.4%) |
HBs-Ag (+) | 116 (83.5%) |
HCV-Ab (+) | 8 (6.2%) |
Tumor size (cm)** | 7.0 (5.0–10.0) |
Tumor number | |
Solitary | 98 (76.0%) |
Multiple | 31 (24.0%) |
Tumor differentiation | |
Well or moderately | 67 (51.9%) |
Poorly | 62 (48.1%) |
Preoperative TAE | |
Yes | 18 (14.0%) |
No | 111 (86.0%) |
Hepatic inflow occlusion | |
Yes | 68 (52.7%) |
No | 61 (47.3%) |
Cirrhosis | |
Yes | 89 (69.0%) |
No | 40 (31.0%) |
Portal hypertension | |
Yes | 11 (8.5%) |
No | 118 (91.5%) |
MVI | |
Yes | 24 (18.6%) |
No | 105 (81.4%) |
Shock | |
Yes | 23 (17.8%) |
No | 106 (82.2%) |
Alcohol consumption | |
Yes | 32 (24.8%) |
No | 97 (75.2%) |
Preoperative blood loss (mL) | |
≤ 500 | 69 (49.6%) |
Continued |